Registered number
08548841
Sierra Medtech Limited
Unaudited Filleted Accounts
30 September 2024
Sierra Medtech Limited
Registered number: 08548841
Balance Sheet
as at 30 September 2024
Notes 2024 2023
£ £
Current assets
Debtors 3 2,000 2,000
Cash at bank and in hand 24,460 22,460
26,460 24,460
Creditors: amounts falling due within one year 4 (5,077) (5,053)
Net current assets 21,383 19,407
Net assets 21,383 19,407
Capital and reserves
Called up share capital 111 111
Share premium 24,989 24,989
Profit and loss account (3,717) (5,693)
Shareholders' funds 21,383 19,407
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Ms D E Kleyn
Director
Approved by the board on 5 August 2025
Sierra Medtech Limited
Notes to the Accounts
for the year ended 30 September 2024
1 Accounting policies
Basis of preparation
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
Turnover
Turnover represents the value, net of value added tax and discounts, of goods provided to customers and work carried out in respect of services provided to customers.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 2 2
3 Debtors 2024 2023
£ £
Other debtors 2,000 2,000
4 Creditors: amounts falling due within one year 2024 2023
£ £
Other creditors 5,077 5,053
5 Other information
Sierra Medtech Limited is a private company limited by shares and incorporated in England. Its registered office is:
2 Hinksey Court
Church Way
Oxford
Oxfordshire
OX2 9SX
Sierra Medtech Limited 08548841 false 2023-10-01 2024-09-30 2024-09-30 VT Final Accounts July 2024 Ms D E Kleyn No description of principal activity 08548841 2022-10-01 2023-09-30 08548841 core:WithinOneYear 2023-09-30 08548841 core:ShareCapital 2023-09-30 08548841 core:SharePremium 2023-09-30 08548841 core:RetainedEarningsAccumulatedLosses 2023-09-30 08548841 2023-10-01 2024-09-30 08548841 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 08548841 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 08548841 bus:Director40 2023-10-01 2024-09-30 08548841 1 2023-10-01 2024-09-30 08548841 2 2023-10-01 2024-09-30 08548841 countries:England 2023-10-01 2024-09-30 08548841 bus:FRS102 2023-10-01 2024-09-30 08548841 bus:FilletedAccounts 2023-10-01 2024-09-30 08548841 2024-09-30 08548841 core:WithinOneYear 2024-09-30 08548841 core:ShareCapital 2024-09-30 08548841 core:SharePremium 2024-09-30 08548841 core:RetainedEarningsAccumulatedLosses 2024-09-30 08548841 2023-09-30 iso4217:GBP xbrli:pure